Staffing: 2024’s Biggest Lab Operations Challenge
ADLM president Anthony Killeen looks at labs’ staffing struggles in 2024 and what can be done to alleviate them in the coming year
Keeps You Up-to-Date on Lab Business and Competitive Strategy, Market Trends and Opportunities, and M&A and Investment Activity in Today’s Diagnostic Lab Industry
ADLM president Anthony Killeen looks at labs’ staffing struggles in 2024 and what can be done to alleviate them in the coming year
The new rules, which were approved by the FTC in October and will go into effect in mid-January, aim to put a damper on consolidation
With strikes increasing across industries, what happens if workers involved in the ancillary services labs depend on go on strike?
$152.1 million SYNLAB deal is expected to create a new channel for Labcorp to market its sophisticated specialty assays
CEO Laurie Menser discusses the Association for Molecular Pathology’s court case against the FDA’s rule on laboratory-developed tests.
Why ongoing coaching and learning is required for laboratory sales reps—even experienced ones—to help labs meet their business goals
The rounds of funding to Clarapath, PreciseDx, and Precision Epigenomics come at a time when other M&A activity is seasonally slow
The agency has approved fewer than 10 tests in the past three years, but a new pipeline of AI-powered products is expected to emerge soon
A guide to understanding, implementing, and benefiting from digital pathology and artificial intelligence in the clinical lab
What labs need to know about keeping patients’ data safe when using digital pathology and artificial intelligence-based solutions
Lee Fleisher, MD, advocates for clearer interpretation of test results by medical laboratory scientists